Studies related to Migraine and Coenzyme Q10

A Randomized, Double-blinded, Placebo-controlled, Crossover, Add-on Study Of CoEnzyme Q10 In The Prevention Of Pediatric And Adolescent Migraine

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 50
Sex Both Genders
Age Range 1-6, 7-12, 13-17
Body Types Average
Notes for this study:
In children and adolescents, CoQ10 supplementation reduced migraine and headache frequency significantly during weeks 1-4 of the trial, to a greater extent than placebo. In the latter portions of the trial, there were no differences between CoQ10 and Placebo.

CoQ10 was administered at 100mg daily.

Full details on all 6 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.